DREAM3R: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural mesothelioma: A phase 3 randomised trial Meeting Abstract
| Authors: | Forde, P.; Kindler, H.; Zauderer, M.; Sun, Z.; Ramalingam, S.; Anagnostou, V.; Brahmer, J. R.; Nowak, A. K.; Kok, P. S.; Brown, C.; Yip, S.; Cook, A.; Lesterhuis, W. J.; Hughes, B. G. M.; Pavlakis, N.; Stockler, M. R.; O'Byrne, K. J. |
| Abstract Title: | DREAM3R: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural mesothelioma: A phase 3 randomised trial |
| Meeting Title: | 2021 Multidisciplinary Thoracic Cancers Symposium |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 112 |
| Issue: | 2 |
| Meeting Dates: | 2021 Dec 2-4 |
| Meeting Location: | Virtual |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-02-01 |
| Start Page: | e9 |
| End Page: | e10 |
| Language: | English |
| DOI: | 10.1016/j.ijrobp.2021.10.177 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 102 -- Accession Number: 154338724 -- Entry Date: In Process -- Revision Date: 20211230 -- Publication Type: Article -- Journal Subset: Biomedical; Peer Reviewed; USA -- NLM UID: 7603616. -- Source: Cinahl |
